Frontlight ResearchEarly access
Not yet taking people in United StatesNo phase
Kore Fiber PLF Study
Key facts
- Who runs it
- Kolosis Bio, LLC
- Where
- Columbus, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 75 people, planned
- Started
- Nov 2026
- Expected to end
- Nov 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Kore Fiber
- Autologous bone graft
- Record updated
- 22 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Age ≥18 years
- Is undergoing standard of care of one- to four-level instrumented posterolateral fusion between L1 and S1
- Has failed 6 months or more of conservative, non-operative treatment
- Able to provide informed consent
- Agree to comply with study protocol
Who cannot take part
- Prior lumbar fusion surgery at the index levels planned for study treatment
- Minimally invasive/tubular surgery
- Active or recent malignancy (within 3 years), or current treatment with chemotherapy, radiation, immunosuppressive agents, or chronic steroids
- History of osteoporosis, osteopenia, osteomalacia, or osteoporotic fracture that may compromise fusion outcomes
- Active systemic infection or localized infection at the operative site
- Cognitive, psychological, or neurological condition that may interfere with pain assessment or study compliance
- Pregnant or planning pregnancy during the study period
- Member of a vulnerable population (e.g., prisoners, cognitively impaired, unable to consent)
- Body mass index (BMI) > 45 kg/m²
Where in United States
- The Ohio State University -Wexner Medical CenterColumbus, United StatesContact: Clinical Research ManagerNot yet recruiting
About the trial
What the trial wants to find out
This is a prospective, randomized controlled trial evaluating Kore Fiber® versus autograft in adults undergoing posterolateral lumbar fusion (PLF). Participants will receive Kore Fiber on one side of the spine and autograft on the opposite side according to randomized assignment. Fusion outcomes, pain outcomes, and safety will be assessed over 12 months.
The 2 groups in the trial
- Kore FiberTreatment being tested
Kore fiber used standalone in instrumented posterolateral fusion per level at the randomized assigned side
- Autologous bone graftExisting treatment, for comparison
Autologous bone graft used in instrumented posterolateral fusion per level at the randomized assigned control side of the spine.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective, Randomized Controlled Trial of Kore Fiber® Versus Autograft in Posterolateral Lumbar Fusion (PLF)
- Record updated
- 22 October 2026